First Manhattan’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-33
| Closed | -$1K | – | 1514 |
|
|
2022
Q2 | $1K | Hold |
33
| – | – | ﹤0.01% | 1466 |
|
|
2022
Q1 | $1K | Hold |
33
| – | – | ﹤0.01% | 1516 |
|
|
2021
Q4 | $2K | Hold |
33
| – | – | ﹤0.01% | 1468 |
|
|
2021
Q3 | $1K | Hold |
33
| – | – | ﹤0.01% | 1538 |
|
|
2021
Q2 | $1K | Hold |
33
| – | – | ﹤0.01% | 1519 |
|
|
2021
Q1 | $1K | Hold |
33
| – | – | ﹤0.01% | 1433 |
|
|
2020
Q4 | $2K | Sell |
33
-234
| -88% | -$14.2K | ﹤0.01% | 1271 |
|
|
2020
Q3 | $67K | Hold |
267
| – | – | ﹤0.01% | 831 |
|
|
2020
Q2 | $44K | Hold |
267
| – | – | ﹤0.01% | 893 |
|
|
2020
Q1 | $18K | Hold |
267
| – | – | ﹤0.01% | 1017 |
|
|
2019
Q4 | $17K | Hold |
267
| – | – | ﹤0.01% | 1073 |
|
|
2019
Q3 | $15K | Buy |
267
+34
| +15% | +$1.91K | ﹤0.01% | 1099 |
|
|
2019
Q2 | $13K | Hold |
233
| – | – | ﹤0.01% | 1150 |
|
|
2019
Q1 | $15K | Hold |
233
| – | – | ﹤0.01% | 1143 |
|
|
2018
Q4 | $12K | Hold |
233
| – | – | ﹤0.01% | 1140 |
|
|
2018
Q3 | $13K | Hold |
233
| – | – | ﹤0.01% | 1187 |
|
|
2018
Q2 | $13K | Hold |
233
| – | – | ﹤0.01% | 1156 |
|
|
2018
Q1 | $11K | Hold |
233
| – | – | ﹤0.01% | 1173 |
|
|
2017
Q4 | $13K | Hold |
233
| – | – | ﹤0.01% | 1207 |
|
|
2017
Q3 | $14K | Buy |
+233
| New | +$14K | ﹤0.01% | 1170 |
|